Skip to content
Disclosery

Decheng Capital Management III (Cayman), LLC

Follow

13F filer, CIK 1747821, Grand Cayman, Cayman Islands

Decheng Capital Management III (Cayman), LLC reported $263,742,000 across 25 holdings for the quarter ended 2022-06-30, in a 13F-HR filed 2022-08-01. Its ten largest share positions make up 83.14% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-22-084797

Period
2022-06-30
Reported value
$264M
Holdings
25
Top 10 weight
83.14%
New
2
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ZNTLnew+1,824,583$51.3M
HORIZON THERAPEUTICS PLCnew+55,400$4.42M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CHECKMATE PHARMACEUTICALS INexited-1,333,254-$4.25M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2022

Share positions as resolved from 13F-HR 0001104659-22-084797, largest first. % of portfolio is the value over $263,742,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ZNTLZENTALIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: 1,824,583 shares 1,824,583$51.3M19.44%newTimeline
ALPINE IMMUNE SCIENCES INCALPINE IMMUNE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 4,708,288 shares; 2022Q2: 4,708,288 shares 4,708,288$40.1M15.19%0
HLTHQCUE HEALTH INC COM (DE)Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 8,980,909 shares; 2022Q2: 8,980,909 shares 8,980,909$28.7M10.9%0Timeline
ILMNILLUMINA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 154,238 shares; 2022Q2: 154,238 shares 154,238$28.4M10.78%0Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 869,790 shares; 2022Q2: 869,790 shares 869,790$22M8.36%0Timeline
TXG10X GENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 303,984 shares; 2022Q2: 303,984 shares 303,984$13.8M5.22%0Timeline
ALBIREO PHARMA INCALBIREO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 518,342 shares; 2022Q2: 518,342 shares 518,342$10.3M3.9%0
EQEQUILLIUM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 4,447,308 shares; 2022Q2: 4,447,308 shares 4,447,308$9.07M3.44%0Timeline
ADICET BIO INCADICET BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 580,000 shares; 2022Q2: 580,000 shares 580,000$8.47M3.21%0
BYSIBEYONDSPRING INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 4,958,142 shares; 2022Q2: 4,958,142 shares 4,958,142$7.14M2.71%0Timeline
PROMETHEUS BIOSCIENCES INCPROMETHEUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 250,000 shares; 2022Q2: 250,000 shares 250,000$7.06M2.68%0
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 526,329 shares; 2022Q2: 526,329 shares 526,329$6.48M2.46%0Timeline
PACBPACIFIC BIOSCIENCES CALIF INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 1,463,872 shares; 2022Q2: 1,463,872 shares 1,463,872$6.47M2.45%0Timeline
HORIZON THERAPEUTICS PLCHORIZON THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: 55,400 shares 55,400$4.42M1.68%new
SEMA4 HOLDINGS CORPSEMA4 HOLDINGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 3,418,929 shares; 2022Q2: 3,418,929 shares 3,418,929$4.31M1.63%0
Mersana Therapeutics IncMersana Therapeutics IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 904,268 shares; 2022Q2: 904,268 shares 904,268$4.18M1.58%0
AURAAURA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 210,000 shares; 2022Q2: 210,000 shares 210,000$2.98M1.13%0Timeline
AtriCure Inc.AtriCure Inc.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 46,259 shares; 2022Q2: 46,259 shares 46,259$1.89M0.72%0
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 714,285 shares; 2022Q2: 714,285 shares 714,285$1.77M0.67%0Timeline
OWLET INCOWLET INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 898,400 shares; 2022Q2: 898,400 shares 898,400$1.53M0.58%0
Ohr Pharmaceutical IncOhr Pharmaceutical IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 1,000,000 shares; 2022Q2: 1,000,000 shares 1,000,000$1.05M0.4%0
SCYXSCYNEXIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 555,555 shares; 2022Q2: 555,555 shares 555,555$1.03M0.39%0Timeline
NAUTNAUTILUS BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 300,000 shares; 2022Q2: 300,000 shares 300,000$807K0.31%0Timeline
MASS908 DEVICES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 20,000 shares; 2022Q2: 20,000 shares 20,000$412K0.16%0Timeline
SINGULAR GENOMICS SYSTEMS INSINGULAR GENOMICS SYSTEMS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 20,000 shares; 2022Q2: 20,000 shares 20,000$76K0.03%0

Sold out in Q2 2022

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CHECKMATE PHARMACEUTICALS INCHECKMATE PHARMACEUTICALS IN1,333,254$4.25Mshares

How Q2 2022 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-22-084797 base2022-08-01acceptance time not in the bulk data set